Chiome Bioscience leverages cutting-edge antibody technology for drug discovery and development| Shigeru Kobayashi,CEO, Chiome Bioscience Inc. 00:10:00

Share On Facebook Share On Twitter

Revolutionizing antibody development with innovative technology, Chiome Bioscience accelerates drug discovery while pursuing sustainability and market growth through clinical trials and strategic partnerships.

Recent Videos